Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:01:47.395Z.
Calculation as of: 2026-10-06T14:01:47.395Z.
Quote observation: 2026-10-06T13:38:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 28ff4bc206842fc4bf4b39bc6a519bf9e708a216f8b2554427075e3ddc5a9144
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
CytoMed Therapeutics Limited
Market Cap
$10.83M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.90M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.17M
EV/EBIT Ratio
N/A
TTM Avg
13.02x
3Y Avg
13.02x
5Y Avg
13.02x
Market Cap
$10.43M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytoMed Therapeutics Limited (GDTC) | $10.83M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.90M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.67M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.55M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.55M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.14M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | N/A | 13.02x | 13.02x | 13.02x |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.43M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
